IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 221 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  Search
 
  Next article
  Previous article 
  Table of Contents
  
Resource Links
   Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
   Article in PDF (66 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)

 
In This Article
   References

 Article Access Statistics
    Viewed2997    
    Printed135    
    Emailed3    
    PDF Downloaded207    
    Comments [Add]    

Recommend this journal

 


 
CORRESPONDENCE
Year : 2006  |  Volume : 38  |  Issue : 6  |  Page : 438
 

Should banned drugs be mentioned clearly?


Department of Pharmacology, M.P. Shah Medical college, Jamnagar-361008, India

Correspondence Address:
D M Parmar
Department of Pharmacology, M.P. Shah Medical college, Jamnagar-361008
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0253-7613.28217

Rights and Permissions



How to cite this article:
Parmar D M, Jadav S P. Should banned drugs be mentioned clearly?. Indian J Pharmacol 2006;38:438

How to cite this URL:
Parmar D M, Jadav S P. Should banned drugs be mentioned clearly?. Indian J Pharmacol [serial online] 2006 [cited 2020 Nov 27];38:438. Available from: https://www.ijp-online.com/text.asp?2006/38/6/438/28217


We have read the article on "Drugs and non-alcoholic steatohepatitis" by S.K. Das and D.M. Vasudevan (Indian J Pharmacol 2006;38:238-42) with interest. The authors have addressed a very important topic, the information gathered in it will be very useful for pharmacovigilance studies in the future. But it is to be noted that it is worth mentioning the status of dexfenfluramine and fenfluramine in [Table 1] as they are banned in India.

An important issue of the availability of banned medicines over the counter has been raised by Thawani et al . [1] The current status of the marketed drugs, particularly hazardous ones, should be clearly mentioned in the interest of the public. Dexfenfluramine and fenfluramine are listed as banned drugs in India [GSR No. 499 (E) dated: 14-08-1998].[2] In this regard, we feel that the citation of such information will help to increase the awareness about hazardous drugs as well as serve the purpose of pharmacovigilance in the true sense.

 
  References Top

1.Thawani V, Sharma S, Gharpure K. Pharmacovigilance: Is it possible if bannable medicines are available over the counter? Indian J Pharmacol 2005;37:191.  Back to cited text no. 1    
2.Drugs Banned In India. Available from: http://www.cdsco.nic.in/html/Drugsbanned.html.  Back to cited text no. 2    




 

Top
Print this article  Email this article

    

Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow